Open access
1,513
Views
2
CrossRef citations to date
0
Altmetric
Odyssey of Diabetes & Metabolic Disease
Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States
Reema Modya Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
, Juliana Meyersb RTI Health Solutions, Research Triangle Park, NC, USA
, Maria Yua Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, USA
, Keith Davisb RTI Health Solutions, Research Triangle Park, NC, USA
& Joshua A. Levinea Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, USA
Pages 1785-1795
|
Received 11 Mar 2022, Accepted 01 Jun 2022, Published online: 27 Jun 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.